CTSNet Podcasts

Precautions During Aerosolizing Procedures – Part 1

Leanne Harling moderates a discussion about applying precautions during aerosolizing procedures and the commonality between ENT and thoracic surgery. This episode is part 1 of 2.

Telemedicine for the Cardiothoracic Surgeon During the COVID-19 Pandemic and Beyond

Jessica Luc, Shanda Blackmon, Mahesh Ramchandani, and Nahush Mokadam discuss the topic of telemedicine for the cardiothoracic surgeon during the COVID-19 pandemic and beyond.

Definition of Necessary Surgery in the Age of COVID-19: An Interview With Douglas E. Wood

Brian Mitzman interviews CTSNet President Douglas E. Wood about the options for oncologic thoracic surgery during the COVID-19 pandemic.

Cardiac Surgery in the Era of COVID-19: An Interview With Thoralf M. Sundt

Joanna Chikwe interviews Thoralf M. Sundt about cardiac surgery in the era of COVID-19.

COVID-19: An International Perspective – Part 2

Filmed March 18, 2020, Brian Mitzman moderates a discussion on the COVID-19 pandemic with an international group of physicians currently on the front lines. This episode contains part 2 of 2.

COVID-19: An International Perspective – Part 1

Filmed March 18, 2020, Brian Mitzman moderates a discussion on the COVID-19 pandemic with an international group of physicians currently on the front lines. This episode contains part 1 of 2.

Giants of Cardiothoracic Surgery: An Interview With Thomas D’Amico

Joel Dunning interviews Thomas D’Amico, a pioneer in the field of VATS lobectomy.

Pioneers in Cardiac Surgery With John McKenna

Leanne Harling interviews John McKenna about his experience in the device industry side of cardiothoracic surgery.

Roundtable: How to Maximize Efficiency in Clinic and Practice

Shanda Blackmon, Brendon Stiles, Vinay Badhwar, and Robert Cerfolio discuss maximizing efficiency in a cardiothoracic surgery practice.

Surgery for Stage IIIa N2 Disease

Leanne Harling, Doug Mathisen, and Erino Rendina share and debate their approaches to staging, adjuvant therapy, persistent disease, and surgical removal of the primary tumor.